A detailed history of Stratos Wealth Partners, Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 290,370 shares of PFE stock, worth $7.97 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
290,370
Previous 260,263 11.57%
Holding current value
$7.97 Million
Previous $7.28 Million 15.39%
% of portfolio
0.12%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$27.7 - $31.39 $833,963 - $945,058
30,107 Added 11.57%
290,370 $8.4 Million
Q2 2024

Jul 24, 2024

SELL
$25.26 - $29.6 $24,426 - $28,623
-967 Reduced 0.37%
260,263 $7.28 Million
Q1 2024

Apr 16, 2024

BUY
$25.89 - $29.73 $959,250 - $1.1 Million
37,051 Added 16.53%
261,230 $7.25 Million
Q4 2023

Jan 24, 2024

BUY
$26.13 - $33.94 $204,153 - $265,173
7,813 Added 3.61%
224,179 $6.45 Million
Q3 2023

Oct 24, 2023

BUY
$32.09 - $37.51 $423,780 - $495,357
13,206 Added 6.5%
216,366 $7.18 Million
Q2 2023

Jul 18, 2023

BUY
$36.12 - $41.79 $407,036 - $470,931
11,269 Added 5.87%
203,160 $7.45 Million
Q1 2023

Apr 27, 2023

SELL
$39.39 - $51.28 $1.52 Million - $1.97 Million
-38,484 Reduced 16.7%
191,891 $7.83 Million
Q4 2022

Jan 19, 2023

BUY
$41.75 - $54.5 $184,994 - $241,489
4,431 Added 1.96%
230,375 $0
Q3 2022

Oct 24, 2022

SELL
$43.76 - $53.42 $940,708 - $1.15 Million
-21,497 Reduced 8.69%
225,944 $9.89 Million
Q2 2022

Jul 22, 2022

BUY
$46.53 - $55.17 $144,801 - $171,689
3,112 Added 1.27%
247,441 $13 Million
Q1 2022

Apr 26, 2022

SELL
$45.75 - $56.69 $116,205 - $143,992
-2,540 Reduced 1.03%
244,329 $12.6 Million
Q4 2021

Jan 14, 2022

BUY
$41.32 - $61.25 $458,362 - $679,446
11,093 Added 4.7%
246,869 $14.6 Million
Q3 2021

Oct 19, 2021

SELL
$39.25 - $50.42 $634,476 - $815,039
-16,165 Reduced 6.42%
235,776 $10.1 Million
Q2 2021

Jul 19, 2021

BUY
$35.91 - $40.68 $335,004 - $379,503
9,329 Added 3.85%
251,941 $9.87 Million
Q1 2021

Apr 27, 2021

BUY
$33.49 - $37.77 $273,412 - $308,354
8,164 Added 3.48%
242,612 $8.79 Million
Q4 2020

Jan 29, 2021

BUY
$33.47 - $42.56 $734,064 - $933,425
21,932 Added 10.32%
234,448 $8.63 Million
Q3 2020

Oct 29, 2020

BUY
$31.75 - $37.25 $778,033 - $912,811
24,505 Added 13.03%
212,516 $7.8 Million
Q2 2020

Jul 28, 2020

BUY
$30.12 - $36.54 $284,091 - $344,645
9,432 Added 5.28%
188,011 $6.15 Million
Q1 2020

May 04, 2020

BUY
$27.03 - $38.62 $180,857 - $258,406
6,691 Added 3.89%
178,579 $5.83 Million
Q4 2019

Jan 29, 2020

BUY
$32.92 - $37.36 $67,156 - $76,214
2,040 Added 1.2%
171,888 $6.74 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $5.5 Million - $7.13 Million
169,314 Added 31706.74%
169,848 $6.1 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $5.77 Million - $7.48 Million
-177,501 Reduced 99.7%
534 $8.56 Million
Q2 2019

Aug 06, 2019

BUY
$36.98 - $41.52 $44,080 - $49,491
1,192 Added 0.67%
178,035 $7.71 Million
Q1 2019

May 07, 2019

BUY
$37.5 - $41.2 $1.4 Million - $1.54 Million
37,339 Added 26.77%
176,843 $7.51 Million
Q4 2018

Feb 08, 2019

SELL
$38.47 - $43.86 $186,233 - $212,326
-4,841 Reduced 3.35%
139,504 $6.09 Million
Q3 2018

Nov 02, 2018

SELL
$34.47 - $41.81 $501,779 - $608,628
-14,557 Reduced 9.16%
144,345 $6.36 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $494,667 - $527,364
-14,999 Reduced 8.63%
158,902 $5.77 Million
Q1 2018

May 10, 2018

BUY
$31.91 - $37.02 $208,627 - $242,036
6,538 Added 3.91%
173,901 $6.17 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $218,950 - $232,314
6,583 Added 4.09%
167,363 $6.06 Million
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $4.98 Million - $5.49 Million
160,780
160,780 $5.74 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.